ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

New Treatment for Rheumatoid Arthritis Will Undergo Clinical Trials

  [ 54 votes ]   [ Discuss This Article ]
By News release • www.ProHealth.com • May 8, 2000


A Canadian clinical trial will begin at the end of May on the Prosorba® Column, the only new non-drug treatment for rheumatoid arthritis approved by Health Canada. Medexus Inc. and the Canadian Arthritis Network (CAN) recently reached an agreement to conduct further clinical studies of the device which removes harmful antibodies and immune complexes from the blood of patients with rheumatoid arthritis. Medexus Inc. has the exclusive license to distribute the Prosorba® Column in Canada. For company founders, Bruce Clark and Ken d'Entremont, the clinical testing is just one of the many steps that the pair have taken since leaving successful careers to form a new business.

Both Clark and d'Entremont had significant careers within the pharmaceutical industry, but recognized that there were medical and technology areas that could be served by a niche healthcare provider. Their niche was to find medical technologies to help people live a better quality of life. The Prosorba® Column is a significant advancement in the treatment of rheumatoid arthritis. The scientific entrepreneurs understood the importance of the Column's therapeutic technology, especially to women suffering from rheumatoid arthritis.

At present, there are more than 250,000 Canadians who suffer from rheumatoid arthritis, two-thirds of whom are women. It is a chronic, inflammatory condition brought on by the body's immune system attacking cartilage, bone and occasionally organs. Patients undergo a series of drug treatments to combat the symptoms, but some patients have adverse reactions to the long-term effects of these treatments. As well, the drugs cannot be taken if a patient is pregnant. Cypress Bioscience Inc., the developer of the Prosorba® Column granted an exclusive license to Medexus Inc. Getting the licensing agreement was only the first step. Clark and d'Entremont then had to seek Health Canada approval to use the Prosorba Column. Health Canada granted approval in February and the agreement with CAN was signed at the end of March. The clinical trials are essential to the successful use of the device in Canada. Dr. Edward Keystone, CAN's associate clinical director and director of the centre for advanced therapeutics in arthritis at Mt. Sinai Hospital in Toronto, emphasizes that clinical trials are a rigorous method of evaluating the effectiveness and safety of new treatments for diseases. "This trial will be particularly important for people who have found that conventional medical therapy for rheumatoid arthritis has not helped them, or for patients who do not want to use those medications as part of their treatments." The treatment involves passing some of the patient's blood through the coffee cup sized Prosorba® column. A protein inside the column binds tightly to the antibodies present in the patient's plasma.

These antibodies "stick" to the protein and stay in the column. The patient then receives the treated blood. Patients undergo one treatment per week for 12 weeks and generally do not have to take any further treatments for about a year. Clark and d'Entremont have also launched another product, a device that helps men with urinary incontinence. The two men are confident that as the demand for new therapies and treatments grows, Medexus Inc. will grow as well. "Helping people with chronic conditions and improving the quality of life is more than just good business," says d'Entremont. "It's also a way of giving something back to society."

Sources: Canadian Arthritis Network, EurekAlert



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor® Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Block food Cravings At Their Molecular Root Block food Cravings At Their Molecular Root
Sunshine Vitamin Has D-lightful Health Benefits Sunshine Vitamin Has D-lightful Health Benefits
The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol
Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map